<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Anticancer therapy relies on targeting highly proliferative cells </plain></SENT>
<SENT sid="1" pm="."><plain>Commonly used chemotherapy does not selectively target individual <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells </plain></SENT>
<SENT sid="2" pm="."><plain>The identification of distinct <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem cells that have the unique ability to engraft <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> and maintain <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> self-renewal may prove vital in the development of novel and selective anticancer therapy </plain></SENT>
<SENT sid="3" pm="."><plain>Therefore, the discovery of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> stem cell markers has attracted much attention </plain></SENT>
<SENT sid="4" pm="."><plain>However, it is still controversial whether current markers for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell subpopulations are selectively labeling <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem cells, whether these markers contribute to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem cell function and how many cells within <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> maintain this stemness </plain></SENT>
<SENT sid="5" pm="."><plain>For this reason, novel anticancer drug approaches need to be considered, that target selective cell <z:hpo ids='HP_0011420'>death</z:hpo> pathways, the tissue microenvironment and, additionally, multiple specific <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (stem) cell markers </plain></SENT>
<SENT sid="6" pm="."><plain>This triple approach of anticancer therapy may contribute to novel chemotherapeutic strategies and improve the understanding of human intestinal <z:mp ids='MP_0002006'>tumorigenesis</z:mp>; in particular, the distinct contribution of human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem cells </plain></SENT>
</text></document>